Compound
    Moderate Evidence

    Phosphatidylcholine

    Phosphatidylcholine

    TL;DR

    Phosphatidylcholine is the most abundant phospholipid in cell membranes; as a supplement it supports liver fat export and choline status, with the strongest human evidence in fatty liver and pregnancy choline needs.

    Ideal For

    • People with low choline intake (little egg/meat consumption)
    • Pregnant women not meeting choline targets
    • Those supporting liver health alongside alcohol reduction

    Avoid If

    • You have a soy allergy (soy-derived products)
    • You already use high-dose alpha-GPC or CDP-choline (redundant)

    Frequently Asked Questions

    Overview

    PC serves two functions: it is a choline donor (about 13-15% choline by weight) and a direct membrane/lipoprotein substrate. Choline deficiency causes fatty liver in controlled feeding studies, and PC (as polyenylphosphatidylcholine, PPC) has been tested in alcoholic and non-alcoholic liver disease with mixed but encouraging results on fibrosis markers. During pregnancy, choline demand rises sharply and PC-rich supplements help meet the 450-550mg/day target. As a nootropic, PC is a weaker acetylcholine booster than alpha-GPC or CDP-choline because plasma choline spikes are modest. Sources differ: soy lecithin is cheapest; sunflower lecithin suits soy-avoiders; purified PPC (e.g., Essentiale-style) has the best liver evidence.

    How It Works

    • Provides choline for phosphatidylcholine synthesis, required to build VLDL particles that export triglycerides from the liver
    • Choline is converted to acetylcholine, supporting cholinergic neurotransmission
    • PPC integrates into hepatocyte membranes, reducing lipid peroxidation in preclinical liver injury models
    • Methyl-group donor via betaine pathway, supporting homocysteine metabolism

    Benefits & Outcomes

    Liver Protection

    Liver and Detox
    Mixed evidence
    Moderate Evidence

    Sensible for people with low choline intake or documented deficiency; benefits in established liver disease are unproven.

    Health Concerns Addressed

    No linked health concerns yet.

    Supporting Research
    6 studies

    Lecithin for dementia and cognitive impairment

    Score: 9/10
    2003
    meta_analysis
    n=376

    Higgins JPT, Flicker L

    No clear benefit of lecithin was found for Alzheimer disease or unclassified dementia on any cognitive outcome

    View source

    First multicenter study of modified release phosphatidylcholine LT-02 in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses

    Score: 8/10
    2014
    rct
    n=156

    Karner M, Kocjan A, Stein J +9 more

    Remission rates were higher with LT-02 than placebo, but the primary endpoint of change in disease activity did not reach significance for all doses

    View source

    Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

    Score: 8/10
    2013
    observational
    n=4007

    Tang WHW, Wang Z, Levison BS +5 more

    Dietary phosphatidylcholine was metabolized by gut microbiota to TMAO, and higher fasting TMAO levels predicted increased risk of major adverse cardiovascular events

    View source

    Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial

    Score: 7/10
    2007
    rct
    n=60

    Stremmel W, Ehehalt R, Autschbach F +1 more

    Complete steroid withdrawal was achieved in 80% of phosphatidylcholine patients versus 10% of placebo patients

    View source

    Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study

    Score: 6/10
    2010
    rct
    n=60

    Stremmel W, Braun A, Hanemann A +3 more

    Clinical remission and mucosal healing improved with increasing phosphatidylcholine doses compared with baseline

    View source

    Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities

    Score: 4/10
    2020
    observational
    n=2843

    Maev IV, Samsonov AA, Palgova LK +4 more

    Ultrasound-assessed steatosis and liver enzymes improved over 24 weeks of phosphatidylcholine treatment

    View source

    Safety Information

    Potential Side Effects

    {"Fishy body odor at high choline intakes (TMA production)","Nausea or loose stools at high doses"}

    Contraindications

    {"Severe soy allergy (soy lecithin forms)"}

    Drug Interactions

    • None major; theoretical additive cholinergic effects with acetylcholinesterase inhibitors

    Pregnancy & Breastfeeding

    Pregnancy: likely_safe

    Breastfeeding: likely_safe

    Dosage Guidelines

    Dosage Used in Studies

    Consult healthcare provider

    Forms Compared

    Food & Timing

    With meals to reduce GI upset.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.